Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.20    -0.40 (-0.20%)
Bid:
201.20
Ask:
203.00
Spread: 1.80 (0.895%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

End of Stabilisation

24 Oct 2006 07:02

Ashmore Group PLC24 October 2006 These written materials are not for distribution (directly or indirectly) in orto the United States, Canada, Australia or Japan. They are not an offer ofsecurities for sale in or into the United States, Canada, Australia or Japan. The Shares of the Company are not being registered under the US Securities Actof 1933, as amended (the 'Securities Act') and may not be offered or sold in theUnited States unless registered under the Securities Act or pursuant to anexemption from such registration. No money, securities or other considerationis being solicited and, if sent in response to the information contained herein,will not be accepted. 24 October 2006 Ashmore Group plc ('Ashmore' or the 'Company') Announcement of Utilisation of Over-allotment Option: Ashmore Group plc In connection with the Placing in relation to the following ordinary shares: Ashmore Group plc ordinary shares of 0.01p eachISIN Code: GB00B132NW22 Ashmore announces that, in connection with the Placing of 177,266,000 ordinaryshares by Ashmore, UBS Limited, as stabilising manager, has given notice toutilise the Over-allotment Option in full in respect of 17,726,600 ordinaryshares in Ashmore. None of the £30.1 million gross proceeds arising from theutilisation of the Over-allotment Option will be received by Ashmore. Including the utilisation of the Over-allotment Option, the total size of thePlacing is 194,992,600 ordinary shares. Following the utilisation of theOver-allotment Option and as a consequence of the Over-allotment Arrangements,Mark Coombs will be beneficially interested in 303,324,200 Ashmore ordinaryshares and Jon Moulton will be beneficially interested in 30,511,700 Ashmoreordinary shares. The Placing Price of Ashmore ordinary shares of 0.01p each was set at 170p perordinary share on 12 October 2006. UBS Limited, as stabilising manager has also informed the Company that thestabilisation period which commenced at 8am on 12 October 2006 has now ended andthat it made no stabilisation trades. Further details in respect of the Over-allotment Option and the Over-allotmentArrangements are set out in Ashmore's Prospectus dated 12 October 2006. Defined terms used in this announcement have the same meaning as in theCompany's Prospectus dated 12 October 2006 unless the context requiresotherwise. This announcement may not be distributed, directly or indirectly, in or into theUnited States, Canada, Australia or Japan. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of Ashmore Group plc in any jurisdiction. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the 'Prospectus Directive') beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and thePlacing are only addressed to and directed at persons in that Member State whoare qualified investors within the meaning of the Prospectus Directive (or whoare other persons to whom the offer may lawfully be addressed) and must not beacted on or relied on by other persons in that Member State. The Placing and the distribution of this announcement and other information inconnection with the Placing in certain jurisdictions may be restricted by lawand persons into whose possession any document or other information referred toherein comes should inform themselves about and observe any such restriction.Any failure to comply with these restrictions may constitute a violation of thesecurities laws of any such jurisdiction. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the U.S.Securities Act of 1933 and may not be offered or sold in the United Statesabsent registration or an exemption from registration. There will be no publicoffer of securities in the United States. Stabilisation/FSA END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.